CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy adults, patients with atopic derm...
Phase 1
Saint Joseph, Missouri, United States and 13 other locations
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Phase 2
Saint Joseph, Missouri, United States and 16 other locations
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Phase 2
St. Joseph, Missouri, United States and 22 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Overland Park, Kansas, United States and 540 other locations
assigned dose or be reassigned to a different dose based on their Eczema Area and Severity Index (EASI) response. Approximately 300 adult pa...
Phase 3
Saint Joseph, Missouri, United States of America and 95 other locations
The primary objective of this study is to assess successful self-administration of rocatinlimab subcutaneously using devices for injection.
Phase 3
Leawood, Kansas, United States of America and 46 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Leawood, Kansas, United States of America and 556 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...
Phase 3
Overland Park, Kansas, United States and 193 other locations
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Phase 3
Shawnee Mission, Kansas, United States and 342 other locations
Clinical trials
Research sites
Resources
Legal